Healthcare and Biotech M&A: Capital Ideas TV

Capital Ideas publisher Mark Bunting speaks with Lexagene Holdings (TSXV:LXG) CEO Dr. Jack Regan about healthcare and biotech M&A

SmallCapPower partner Capital Ideas presents a special segment of Capital Ideas TV. In this episode, Capital Ideas Media publisher Mark Bunting speaks with Dr. Jack Regan, founder and CEO of Lexagene Holdings Inc (TSXV:LXG) (OTC:LXXGF). The Company is on the verge of commercializing its pathogen detection system, which is faster and less expensive than current methods. Regan says Lexagene has already had exploratory talks with larger biotech firms that need this technology in their product line. That makes a buyout of Lexagene later this year a distinct possibility.

To read our full disclosure, please click on the button below: